Immunai I

Immunai

AI-driven immunology and drug discovery platform

Immunai builds a machine learning platform that maps immune system data to speed up discovery of immunology-based therapies.

0 tools ·founded 2019 ·New York City, New York
Visit Immunai
// founders
Founders
Noam Solomon, Luis Voloch

No tools listed for this company yet.